TENX
TENX clinical trials: TENAX THERAPEUTICS, INC.
Every trial on ClinicalTrials.gov where TENAX THERAPEUTICS, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 9
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
TENX on the catalyst calendar · TENX registry changes
- Primary completion Mar 2029Sponsor estimatePhase 3NCT07436689Long-Term Open-Label Extension Study of Oral LevosimendanTenax Therapeutics, Inc. · Pulmonary Hypertension Associated With HFpEFEnrolling by invitationTENXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2028Sponsor estimatePhase 3NCT07288398LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2Tenax Therapeutics, Inc. · Pulmonary Hypertension Associated With HFpEFActive, not recruitingTENXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2026ActualPhase 3NCT05983250LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFTenax Therapeutics, Inc. · Pulmonary HypertensionActive, not recruitingTENXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 25, 2023ActualPhase 2NCT03624010Open-Label Rollover Study of Levosimendan in PH-HFpEF PatientsTenax Therapeutics, Inc. · Hypertension Pulmonary Secondary Heart FailureCompletedTENXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2008ActualPhase 2NCT00174980Study of Oxycyte in Severe Closed Head InjuryTenax Therapeutics, Inc. · Traumatic Brain InjuryTerminatedTENXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 7, 2020ActualPhase 2NCT03541603Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEFTenax Therapeutics, Inc. · Hypertension Pulmonary SecondaryCompletedTENXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2016ActualPhase 3NCT02025621Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary BypassTenax Therapeutics, Inc. · Coronary Artery Bypass GraftingCompletedTENXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT02973620Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart FailureTenax Therapeutics, Inc. · Heart DecompensationNo longer availableTENXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2014ActualPhase 2NCT00908063Safety and Tolerability of Oxycyte in Patients With Traumatic Brain Injury (TBI)Tenax Therapeutics, Inc. · Traumatic Brain InjuryTerminatedTENXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner